Calamos Wealth Management »

Royalty Pharma shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 78k 47.97

More positions owned by Calamos Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Msci Acwi Ex Us (ACWX)
Broadcom (AVGO)
Victory Portfolios Ii Core Intermediat (UITB)
Ishares Tr Russell 3000 Etf (IWV)
Meta Platforms Cl A (META)
Calamos Etf Tr Autocallable Inc (CAIE)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Calamos Wealth Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma